BioSpace News Archive

Drug Development

Virometix Announces Initiation of Phase 1 Clinical Trial With Its V-306 Vaccine Candidate

Virometix is pleased to announce that the Belgian health authority, FAMHP, has approved the company’s clinical trial application for the first-in-human phase 1 study of its respiratory syncytial virus vaccine candidate, V-306 in healthy volunteers.

March 12, 2020
·
3 min read
Business

RadNet Reports Record Fourth Quarter and Full Year 2019 Results and Releases 2020 Financial Guidance

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 335 owned and/or operated outpatient imaging centers, reported financial results for its fourth quarter and full year ended December 31, 2019.

March 12, 2020
·
15 min read
Business

Hylant Announces Exclusive Partnership With Regenexx to Reduce Orthopedic Surgical Spend for Employers

Hylant excited to announce a unique partnership with Regenexx to offer access to non-surgical orthopedic alternatives to Hylant self-funded employer groups

March 12, 2020
·
2 min read
Business

Leading Psychedelic Pharmaceutical Company MindMed Forms New Board Committee To Evaluate Acquisitions And Scientific Collaborations

John Hopkins professor and psychedelics expert Matthew Johnson to act as senior advisor to committee

March 12, 2020
·
5 min read
Business

Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year Ended December 31, 2019 Results

Apollo Medical Holdings, Inc., an integrated population health management company, announced its consolidated financial results for the fourth quarter and year ended December 31, 2019.

March 12, 2020
·
15 min read
Deals

WebMD Acquires the StayWell Company

WebMD Health Corp., an Internet Brands company and the leader in health information services for consumers, physicians, and other healthcare professionals, announced that it has acquired The StayWell Company, a subsidiary of Merck, known as MSD outside the United States and Canada.

March 12, 2020
·
3 min read
Business

EmblemHealth Announces Partnership with Medly Pharmacy for Prescription Home Delivery Services as COVID-19 Cases Increase

Home Delivery Program Will Bring Prescriptions to Doorsteps for Members Wishing to Avoid Exposure to COVID-19

March 12, 2020
·
2 min read
Policy

Sumitomo Heavy Industries, Ltd. Obtains Medical Device Approval for Manufacturing and Sales of Accelerator Based BNCT System and the Dose Calculation Program in Japan

Sumitomo Heavy Industries, Ltd. has performed clinical trial of the BNCT*1) (Boron Neutron Capture Therapy) system using an accelerator (cyclotron), targeting carcinoma of the head and neck region in collaboration with STELLA PHARMA CORPORATION

March 12, 2020
·
1 min read
Policy

Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®▼ (fremanezumab)

Teva Pharmaceutical Europe BV an affiliate of Teva Pharmaceutical Industries Ltd. announced that the National Institute for Health and Care Excellence has recommended AJOVY in its Final Appraisal Document for the prevention of migraine in adults with chronic migraine.

March 12, 2020
·
7 min read
Achieve Life Sciences Announces Presentation of Additional Cytisinicline Analyses at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting

Achieve Life Sciences, Inc. announced that additional analyses from the ORCA-1 Phase 2b trial will be presented today, Thursday, March 12th, at the SRNT Annual Meeting in New Orleans.

March 12, 2020
·
6 min read